Please assess the completion status of the following clinical trial:

Trial Title: Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;~2. Males or females, \>18 years of age inclusive at the time of study screening;~3. American Society of Anesthesiologists (ASA) Class I-III;~4. Infraperitoneal colorectal surgery (open and/or laparoscopic);~5. Elective Surgery~Exclusion Criteria:~1. Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures;~2. Children \<18;~3. No perioperative antibiotics;~4. Past or current urinary tract malignancy;~5. Urinary catheter inserted before surgery;~6. Chronic kidney insufficiency with Creatinine\> 2~7. Diagnosis of benign prostatic hyperplasia~8. Chronic urinary infections~9. Neurogenic bladder~10. History of enterovesical fistula~11. Pregnancy~12. Prior surgery of the lower urinary tract~13. Epidural~14. Perioperative ureteral stents~After randomization:~1. Catheter pulled out inadvertently;~2. Postoperative complications requiring prolonged monitoring of urine output~3. Postoperative complications requiring early reoperation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 24 hour postop catheter removal (Type: EXPERIMENTAL): group will receive the study medication prazosin ( 1 mg PO) 6 hours prior to catheter discontinuation (24 hours postoperatively)
- 72 hour postoperative catheter removal (Type: NO_INTERVENTION): catheter removed on postoperative day 3 (72 hours postoperatively)

Based on this trial design, predict the completion outcome and termination type (if applicable).